Motus GI Holdings Pre-Tax Profit Margin 2016-2024 | MOTS
Motus GI Holdings pre-tax profit margin from 2016 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Motus GI Holdings Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-03-31 | $0.00B | $-0.01B | 0.00% |
| 2023-12-31 | $0.00B | $-0.01B | 0.00% |
| 2023-09-30 | $0.00B | $-0.01B | 0.00% |
| 2023-06-30 | $0.00B | $-0.02B | 0.00% |
| 2023-03-31 | $0.00B | $-0.02B | 0.00% |
| 2022-12-31 | $0.00B | $-0.02B | 0.00% |
| 2022-09-30 | $0.00B | $-0.02B | 0.00% |
| 2022-06-30 | $0.00B | $-0.02B | 0.00% |
| 2022-03-31 | $0.00B | $-0.02B | 0.00% |
| 2021-12-31 | $0.00B | $-0.02B | 0.00% |
| 2021-09-30 | $0.00B | $-0.02B | 0.00% |
| 2021-06-30 | $0.00B | $-0.02B | 0.00% |
| 2021-03-31 | $0.00B | $-0.02B | 0.00% |
| 2020-12-31 | $0.00B | $-0.02B | 0.00% |
| 2020-09-30 | $0.00B | $-0.02B | 0.00% |
| 2020-06-30 | $0.00B | $-0.02B | 0.00% |
| 2020-03-31 | $0.00B | $-0.02B | 0.00% |
| 2019-12-31 | $0.00B | $-0.02B | 0.00% |
| 2019-09-30 | $0.00B | $-0.02B | 0.00% |
| 2019-03-31 | $0.00B | $-0.02B | 0.00% |
| 2018-12-31 | $0.00B | $-0.02B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also operates through subsidiaries in the U.S. and Israel. Motus GI Holdings, Inc. is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.880B | 26.54 |
| Tempus AI (TEM) | United States | $8.592B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.763B | 279.50 |
| Hinge Health (HNGE) | United States | $5.328B | 0.00 |
| 10x Genomics (TXG) | United States | $4.182B | 0.00 |
| Doximity (DOCS) | United States | $3.670B | 19.30 |
| IRhythm Holdings (IRTC) | United States | $3.440B | 0.00 |
| Privia Health (PRVA) | United States | $2.960B | 146.81 |
| Heartflow (HTFL) | United States | $2.918B | 0.00 |
| Clover Health Investments (CLOV) | United States | $2.707B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.851B | 0.00 |
| Omnicell (OMCL) | United States | $1.759B | 35.81 |
| Enovis (ENOV) | United States | $1.226B | 6.30 |
| Inspire Medical Systems (INSP) | United States | $1.191B | 16.03 |
| Schrodinger (SDGR) | United States | $1.124B | 0.00 |
| Azenta (AZTA) | United States | $1.026B | 49.49 |
| Talkspace (TALK) | United States | $0.873B | 521.00 |
| Veradigm (MDRX) | United States | $0.612B | 0.00 |
| Phreesia (PHR) | United States | $0.551B | 31.86 |
| Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
| Evolent Health (EVH) | United States | $0.504B | 0.00 |
| Claritev (CTEV) | United States | $0.485B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.448B | 0.00 |
| TruBridge (TBRG) | United States | $0.392B | 11.35 |
| CapsoVision (CV) | United States | $0.324B | 0.00 |
| Standard BioTools (LAB) | United States | $0.302B | 0.00 |
| Carlsmed (CARL) | United States | $0.268B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.266B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.177B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.174B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.127B | 0.00 |
| Outset Medical (OM) | United States | $0.090B | 0.00 |
| CareCloud (CCLD) | United States | $0.090B | 6.42 |
| P3 Health Partners (PIII) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.071B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.061B | 0.00 |
| Pulmonx (LUNG) | United States | $0.054B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| 111 (YI) | China | $0.033B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.029B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.019B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.000B | 0.00 |